UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Stonegate Investment Group LLC

Stonegate Investment Group LLC cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 41.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,394 shares of the healthcare conglomerate's stock after selling 7,261 shares during the period. Stonegate Investment Group LLC's holdings in UnitedHealth Group were worth $5,444,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. NewSquare Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $26,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at about $28,000. Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group during the fourth quarter worth approximately $30,000. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $32,000. Institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Bank of America downgraded shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their target price for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Truist Financial restated a "buy" rating and set a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Robert W. Baird downgraded UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 target price for the company. in a research report on Wednesday, June 11th. Finally, Baird R W downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, June 11th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average target price of $427.09.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of the firm's stock in a transaction on Wednesday, May 14th. The stock was acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Kristen Gil acquired 3,700 shares of the company's stock in a transaction on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director now owns 3,818 shares of the company's stock, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is owned by insiders.

UnitedHealth Group Stock Down 1.7%

Shares of UnitedHealth Group stock traded down $5.16 during trading on Friday, reaching $302.04. The company's stock had a trading volume of 16,024,789 shares, compared to its average volume of 7,346,801. The company has a 50-day simple moving average of $359.15 and a two-hundred day simple moving average of $462.77. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The company has a market cap of $273.99 billion, a price-to-earnings ratio of 12.65, a P/E/G ratio of 1.42 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the previous year, the company posted $6.91 EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.93%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. UnitedHealth Group's payout ratio is presently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.